Coverage is limited based on diagnosis: For type 2 diabetes, CHAMPVA covers Mounjaro, Ozempic, Rybelsus, Trulicity, and Victoza For moderate to severe obstructive sleep apnea, verified by a sleep study within the past 12 months, CHAMPVA covers Zepbound For metabolic-associated steatohepatitis (MASH) or prevention of major adverse cardiovascular events (MACE), CHAMPVA covers Wegovy Prior authorization is required for Wegovy and Zepbound
[49] S-acetyl-glutathione is also known to have antiviral and immunomodulatory properties
V., Bardymov, V
For health plans including these drugs on their prescription drug formularies, utilization management tools, like prior authorization and step therapy, can be used to allow medically indicated access to the drugs while controlling costs by tying coverage of the drugs to specific clinical and treatment criteria
Now, as Ive said, this isnt unexpected